Literature DB >> 16227762

Hypertension and cognitive decline: impact on executive function.

Augusto Vicario1, Carlos D Martinez, Dolores Baretto, Alejandra Diaz Casale, Liliana Nicolosi.   

Abstract

Hypertension is a risk factor for mild cognitive deterioration and vascular dementia. Cognitive deterioration attributable to normal aging was distinguished from cognitive deterioration related to hypertension by means of neuropsychologic tests. Sixty hypertensive patients, aged 65-80 years, were compared with 30 normotensive individuals. Patients with a history of stroke and/or transient ischemic attacks, diabetes, atrial fibrillation, hypercholesterolemia, or bypass surgery, and those diagnosed with dementia, depression, or anxiety, were excluded. Neither gender differences, duration of hypertension (10.2+/-8.2 years), nor prescribed antihypertensive drug treatment had an influence on study results. Immediate recall was impaired in both groups. The hypertensive patients evinced impairment in all tests vs. the normotensive subjects. Mean deferred recall scores +/- SD were 5.68+/-2.6 vs. 7.13+/-2.4; p<0.01. Deficits in attention speed and executive function, as measured by nonperformance on the Trail Making Test Part B, were present in 46% of hypertensive patients vs. 13% of normotensive patients (p<0.005), with more errors made by the hypertensive patients (1.15+/-1.54 vs. 0.46+/-0.9; p<0.02). Scores on the Stroop Color and Word Test also revealed deficits in the hypertensive patients (24.7+/-7.6 vs. 32+/-10.7; p<0.005). Compared with the control group, the hypertensive participants revealed more deficits in skills involving delayed recall and prefrontal-region skills. The relevant neuropsychologic tests were sufficiently sensitive and proved easy to use in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227762      PMCID: PMC8109513          DOI: 10.1111/j.1524-6175.2005.04498.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  41 in total

1.  Clinical utility of the Trail Making Test practice time.

Authors:  M D Thompson; J G Scott; S W Dickson; J D Schoenfeld; W D Ruwe; R L Adams
Journal:  Clin Neuropsychol       Date:  1999-11       Impact factor: 3.535

2.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.

Authors:  M F Newman; J L Kirchner; B Phillips-Bute; V Gaver; H Grocott; R H Jones; D B Mark; J G Reves; J A Blumenthal
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

3.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

Authors:  A Ott; M M Breteler; M C de Bruyne; F van Harskamp; D E Grobbee; A Hofman
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

4.  Analysis of an Oral Paradigm for the Trail Making Test

Authors: 
Journal:  Assessment       Date:  1994-03

5.  Psychiatric screening in general practice: comparison of the general health questionnaire and the hospital anxiety depression scale.

Authors:  M J Wilkinson; P Barczak
Journal:  J R Coll Gen Pract       Date:  1988-07

6.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

Review 7.  Hypertension and the risk of dementia in the elderly.

Authors:  F Forette; F Boller
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

8.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

Review 9.  Risk factors for vascular dementia: a review.

Authors:  I Skoog
Journal:  Dementia       Date:  1994 May-Aug

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  28 in total

1.  Blood pressure and cognition among older adults: a meta-analysis.

Authors:  Katherine A Gifford; Maria Badaracco; Dandan Liu; Yorghos Tripodis; Amanda Gentile; Zengqi Lu; Joseph Palmisano; Angela L Jefferson
Journal:  Arch Clin Neuropsychol       Date:  2013-07-09       Impact factor: 2.813

2.  Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire.

Authors:  Kevin R Krull; Gerard Gioia; Kirsten K Ness; Leah Ellenberg; Christopher Recklitis; Wendy Leisenring; Sujuan Huang; Marilyn Stovall; Leslie L Robison; Lonnie Zeltzer
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 3.  Prefrontal cortex and executive functions in healthy adults: a meta-analysis of structural neuroimaging studies.

Authors:  Peng Yuan; Naftali Raz
Journal:  Neurosci Biobehav Rev       Date:  2014-02-23       Impact factor: 8.989

4.  Cognitive enhancement following acute losartan in normotensive young adults.

Authors:  Rasha Mechaeil; Paul Gard; Anne Jackson; Jennifer Rusted
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

Review 5.  At the Heart of Brain Disorders - Preventing Cognitive Decline and Dementia.

Authors:  Augusto Vicario; Gustavo H Cerezo
Journal:  Eur Cardiol       Date:  2015-07

Review 6.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

7.  Periodic Limb Movements in Sleep are Associated with Greater Cognitive Decline in Older Men without Dementia.

Authors:  Yue Leng; Terri Blackwell; Katie L Stone; Tina D Hoang; Susan Redline; Kristine Yaffe
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

8.  Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.

Authors:  Ihab Hajjar; Meaghan Hart; Yu-Ling Chen; Wendy Mack; Vera Novak; Helena C Chui; Lewis Lipsitz
Journal:  J Am Geriatr Soc       Date:  2013-01-25       Impact factor: 5.562

9.  Assessment of cerebrovascular reactivity during resting state breathing and its correlation with cognitive function in hypertension.

Authors:  Ihab Hajjar; Vasilis Marmerelis; Dae C Shin; Helena Chui
Journal:  Cerebrovasc Dis       Date:  2014-08-20       Impact factor: 2.762

10.  Associations between Markers of Glucose and Insulin Function and Cognitive Function in Healthy African American Elders.

Authors:  Jeannine S Skinner; Amy Morgan; Hector Hernandez-Saucedo; Angela Hansen; Selena Corbett; Matthew Arbuckle; James Ba Leverenz; Consuelo H Wilkins; Suzanne Craft; Laura D Baker
Journal:  J Gerontol Geriatr Res       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.